3 best performing ASX shares in the week of 25 April 2022
Marc Kennis, May 1, 2022
Best performing ASX shares
The three best performing ASX shares in the week of 25 April 2022 were Vita Group (ASX:VTG), up 53.8%, Splitit Payments (ASX:SPT), up 40.5%, and Beston Global Food Company (ASX:BFC), up 39.5%.
GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER
1. Vita Group (ASX:VTG)
Industry: Retail
Vita Group (VTG) is involved in sales and marketing of products and services through its networks and brands. Its businesses used to include the Telstra ICT retail store network and the Telstra Business ICT channel, but those have recently been divested. The company currently runs its Skin-Health and Wellness business comprising a number of brands, including Artisan Aesthetics Clinics.
We wrote about VTG just last week when the stock was at 32 cents!
Market Cap: $83m
12 month high / low: $0.25 – $1.04
2. Splitit Payments (ASX:SPT)
Industry: Industrial & Commercial Services
SplitIt Payments (ASX:SPT) is an Israel-based Buy Now Pay Later company focused on the US market.
Market Cap: $122M
12 month high / low: $0.14 – $0.77
3. Beston Global Food Company (ASX:BFC)
Industry: Food & Beverage
Beston Global Food Company (ASX:BFC) is an Australian company involved in the production, marketing and distribution of dairy, seafood, meat, wine, health and nutrition products in local and international markets. It is also involved in processing high pH natural spring water, development and commercialisation of end-to-end food traceability and anti-counterfeit technology.
Market Cap: $52m
12 month high / low: $0.041 – $0.15
Learn more about ASX-listed stocks with
Stocks Down Under!
Subscribe to Stocks Down Under today!
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Trump vs. Jerome Powell: What Happens to the Market If Powell Is Fired?
The relationship between President Donald Trump and Federal Reserve Chair Jerome Powell has often been tumultuous, particularly around decisions regarding…
Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!
What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…
Anti Woke ETFs: Do they practice what they preach and have they outperformed since Trump’s return to power?
Have you ever heard of so-called ‘Anti Woke ETFs’? If you’re sick of companies that are big on ESG, this…